In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.
Amplia Therapeutics Limited Balance Sheet Statement - Assets
As of 31 Mar 2020, The total current assets of Amplia Therapeutics Limited (ASX:ATX) was around $1,177,656 which consisted of $1,108,115 of Cash, no Inventory and $34,227 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.
All amounts in AUD
The latest balance sheet of Amplia Therapeutics Limited also showed $797 of Property Plant Equipment and no Good will. Also there were $7,937,932 of Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $9,116,385.
Amplia Therapeutics Limited Balance Sheet Statement - Liabilities
ATX's latest annual results shows the balance sheet has $474,072 of Accounts Payable. Also there were no Short/Long term debt, no Long term debt, $10,614 of Other Current liabilities and $510,620 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.
As per the 31 Mar 2020's annual report of Amplia Therapeutics Limited, the total liabilities were $510,620.
ATX Balance Sheet Statement - Stock Holder Equity
Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.
The latest Balance sheet of Amplia Therapeutics Limited showed the total stock holder equity was $8,605,765 which consisted of $132,903,135 of Common stocks, $-122,926,082 of Retained earnings and $-1,371,288 of Other stock holder equity.
ATX Balance Sheet Statement History
Following table shows the history of balance sheet for Amplia Therapeutics Limited (ATX).
|31 Mar 2020||31 Mar 2019||31 Mar 2018||31 Mar 2017|
|Total Current Assets||1.18M||1.25M||2.64M||7.37M|
|Property Plant Equipment||797||1.6k||-||162.22k|
|Deferred Long Term Asset Charges||-||-||-||-|
|Short/Long Term Debt||-||-||-||-|
|Other Current Liabilities||10.61k||10.61k||10.61k||10.28k|
|Long Term Debt||-||-||-||-|
|Total Current Liabilities||510.62k||526.86k||279.42k||907.87k|
|Other Stockholder Equity||-1.37M||-1.36M||-350.31k||389.35k|
|Total Stockholder Equity||8.61M||8.66M||2.36M||6.63M|
|Net Tangible Assets||667.83k||726.54k||2.36M||6.63M|
Amplia Therapeutics Limited (ASX:ATX) Balance Sheet Statement FAQ
1. How much Cash Amplia Therapeutics Limited has on their balance sheet?
As of 31 Mar 2020, Amplia Therapeutics Limited (ASX:ATX) has $1,108,115 of Cash.
2. What's the long term debt of Amplia Therapeutics Limited?
As per the latest Balance sheet of Amplia Therapeutics Limited (ASX:ATX), it has no Long term debt.
3. How much share holder equity does Amplia Therapeutics Limited has?
The Amplia Therapeutics Limited (ASX:ATX)'s balance sheet shows that it has $8,605,765 of Total stock holder equity.